CanBas
4575.TTSE GROWTHPharmaceutical
Filed as CanBas Co., Ltd. (2022-09–2026-09)
Financials · Standalone
| Fiscal year ended | 2026-06 | 2025-06 | 2024-06 | 2023-06 | 2022-06 | 2021-06 |
|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | ¥109m |
| Operating income | −¥1.4bn | −¥1.1bn | −¥1.3bn | −¥966m | −¥846m | −¥548m |
| Ordinary income | −¥1.3bn | −¥1.2bn | −¥1.2bn | −¥1.3bn | −¥854m | −¥555m |
| Total assets | ¥1.8bn | ¥3.1bn | ¥2.4bn | ¥2.1bn | ¥791m | ¥1.3bn |
| Net assets / equity | ¥1.6bn | ¥2.9bn | ¥2.3bn | ¥1.9bn | ¥251m | ¥438m |
| Operating cash flow | −¥1.4bn | −¥771m | −¥1.3bn | −¥1.4bn | −¥720m | −¥689m |
| EPS (basic) | ¥-66.42 | ¥-61.14 | ¥-67.9 | ¥-83.03 | ¥-88.31 | ¥-70.01 |
From EDINET filings. Select any figure to open the report it came from. r = changed in a later filing (the report page shows the original). — = not reported in the filings structured so far.
Reports · 13
| Period | Form | Figures |
|---|---|---|
| 2025-07-01 → 2026-06-30 | Annual | 94 figures · EDINET |
| 2025-07-01 → 2025-12-31 | Half-year | 55 figures · EDINET |
| 2024-07-01 → 2025-06-30 | Annual | 97 figures · EDINET |
| 2024-07-01 → 2024-12-31 | Half-year | 56 figures · EDINET |
| 2023-07-01 → 2024-06-30 | Annual | 97 figures · EDINET |
| 2023-07-01 → 2024-03-31 | Quarterly Q3 | 39 figures · EDINET |
| 2023-07-01 → 2023-12-31 | Quarterly Q2 | 58 figures · EDINET |
| 2023-07-01 → 2023-09-30 | Quarterly Q1 | 37 figures · EDINET |
| 2022-07-01 → 2023-06-30 | Annual | 99 figures · EDINET |
| 2022-07-01 → 2023-03-31 | Quarterly Q3 | 39 figures · EDINET |
| 2022-07-01 → 2022-12-31 | Quarterly Q2 | 59 figures · EDINET |
| 2022-07-01 → 2022-09-30 | Quarterly Q1 | 37 figures · EDINET |
| 2021-07-01 → 2022-06-30 | Annual | 102 figures · EDINET |
23 more reports are still being processed.